Lung and breast cancer remain among the leading causes of cancer-related death worldwide. As research, testing and treatment strategies continue to evolve, clinicians must keep abreast of the latest data on molecular mechanisms, emerging therapies, current standards of care, and new strategies for treatment. Whether you are looking for education on the value and interpretation of real-world evidence for clinical decision making in breast cancer care or the efficacy and safety of antibody drug conjugates as therapeutic agents in NSCLC, you’ll find educational activities and resources here to help improve your knowledge and gain insight.
Our activities offer many credit types, including CME, AAFP Prescribed Credit, CNE, CPE, ABIM MOC, and ABP MOC. Each activity has been designed to meet the requirements for CME for MIPS. See each activity’s information page for the exact credit type and amount of credit offered.